David Alexander Forsyth
Gillespie
Investigador no período 2013-2021
Dana–Farber Cancer Institute
Boston, Estados UnidosPublicacións en colaboración con investigadores/as de Dana–Farber Cancer Institute (2)
2015
-
PARP inhibitor olaparib increases the oncolytic activity of dl922-947 in invitro and invivo model of anaplastic thyroid carcinoma
Molecular Oncology, Vol. 9, Núm. 1, pp. 78-92
2013
-
Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells
Endocrine-Related Cancer, Vol. 20, Núm. 5, pp. 633-647